Evaluation of Sex‐Based Differences in the Prescription of the Combination of Evidence‐Based Medicine After the Occurrence of an Acute ST‐Elevation Myocardial Infarction
Clinical Cardiology · 2025
DOI: 10.1002/clc.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Cardiology, 2025. Verfasst von A Evelo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hospital Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Evidence-Based Medicine, Practice Patterns, Physicians'. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Aim
To evaluate sex‐based differences in the prescription of the combination of evidence‐based medicine (cEBM) at discharge after an acute ST‐elevation myocardial infarction (STEMI). Secondly, we analysed risk factors for the absence of cEBM after discharge, and examined sex differences in adverse events.
Methods
This retrospective cohort study compared women to men who were admitted with an acute STEMI at Haga Teaching Hospital between January 2017 and June 2023. The primary outcome was cEBM, defined as an active prescription of the combination of acetylsalicylic acid, P2Y 12 ‐inhibitor, ACEi/ARB, beta‐blocker, and statin/ezetimibe on the day after discharge.
Results
Among 1467 patients (27% women), women were older than men (74 years vs. 65 years, p < 0.001). cEBM was less often prescribed to women than men (66.0% vs. 72.8%, p = 0.013), primarily due to ACEi/ARB (82.1% vs. 87.7%, p = 0.007) and statins (90.2% vs. 95.2%, p = 0.001). In a multivariable logistic regression analysis, female sex was not associated with the absence of cEBM (Odds Ratio (OR) = 1.01, 95% confidence interval [95% CI]: 0.73–1.39). Other confounders such as increasing age, decreasing haemoglobin, and oral anticoagulants were correlated with the absence of cEBM.
Conclusions
A smaller proportion of women were prescribed cEBM post‐STEMI compared to men. However, this difference disappeared when controlled for other confounders. Also, women remained to have a higher chance for a stroke or death at 6 months post‐discharge. These findings highlight the need for further research into sex disparities and their underlying confounders in the field of evidence‐based medicine after an acute STEMI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hospital Pharmacy, Haga Teaching Hospital, The Hague, The Netherlands.
- Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
- Department of Clinical Pharmacy, Rijnstate Hospital, Arnhem, The Netherlands.
- HagaAcademy & Innovation, Haga Teaching Hospital, The Hague, The Netherlands.
- Department of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands.
ORCID-Profile: A Evelo
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Evelo, A., Leegwater, E., Rietdijk, W. J. R., Warning, T. D., Schotborgh, C. E., & Visser, L. E. (2025). Evaluation of Sex‐Based Differences in the Prescription of the Combination of Evidence‐Based Medicine After the Occurrence of an Acute ST‐Elevation Myocardial Infarction. Clinical Cardiology. https://doi.org/10.1002/clc.70195
Vancouver
Evelo A, Leegwater E, Rietdijk WJR, Warning TD, Schotborgh CE, Visser LE. Evaluation of Sex‐Based Differences in the Prescription of the Combination of Evidence‐Based Medicine After the Occurrence of an Acute ST‐Elevation Myocardial Infarction. Clinical Cardiology. 2025. doi:10.1002/clc.70195
BibTeX
@article{Evelo2025,
author = {Evelo, A and Leegwater, E and Rietdijk, W J R and Warning, T D and Schotborgh, C E and Visser, L E},
title = {Evaluation of Sex‐Based Differences in the Prescription of the Combination of Evidence‐Based Medicine After the Occurrence of an Acute ST‐Elevation Myocardial Infarction},
journal = {Clinical Cardiology},
year = {2025},
doi = {10.1002/clc.70195}
}
EUVIMED